EUVIMEDEUVIMED entdecken
Crossref

Metabolic activation and cytotoxicity of carvedilol mediated by cytochrome P450s in vitro and in vivo

Shibo Sun, Yang Wang, Yan Shen, Weiwei Li, Zixia Hu, Ying Peng, Jiang Zheng iD

Archives of Toxicology · 2025

DOI: 10.1007/s00204-025-04054-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, 2025. Verfasst von Shibo Sun und 6 weiteren Autor:innen. Beteiligte Einrichtung: Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, PO Box 21, Shenyang, 110016, Liaoning, People's Republic of China. Hauptthemen laut MEDLINE: Carvedilol, Chemical and Drug Induced Liver Injury, Antihypertensive Agents, Cytochrome P-450 Enzyme System. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carvedilol (CAR) is commonly administered in the treatment of essential hypertension. Current reports suggest that CAR therapy may elevate the risk of hepatotoxicity, occasionally progressing to liver injury. However, the underlying mechanisms of the toxicity remain poor understood. This study investigated CAR-associated hepatotoxicity through reactive metabolites formation. In the microsomal incubation mixture containing CAR (50 μM), four phase I metabolites (M1-M4) were detected. Upon the addition of glutathione (GSH), N-acetylcysteine (NAC), or cysteine as trapping agents, four GSH conjugates (M5-M8), four NAC conjugates (M9-M12), and four cysteine conjugates (M13-M16) were also detected. Chemical synthesis of 8-hydroxy CAR identified M1 as the primary oxidative metabolite of CAR. Following the administration of CAR (25 mg/kg), we detected GSH conjugate (M5) in bile, NAC conjugate (M9) in urine, and cysteine adduct (M13) in proteolytic mixture of liver tissues of rat. Furthermore, it was found that CYP3A4 dominated the metabolic activation of CAR. Additionally, CAR exhibited time-course changes and dose-dependent (0, 25, 50, and 100 mg/kg) protein adduction in rat liver tissues, as well as time- and concentration-dependent (0, 10, 25, 50 and 100 μM) inhibition of hepatocyte viability. Ketoconazole (KTZ) significantly decreased the susceptibility of hepatocytes to CAR-induced cytotoxicity. Collectively, these findings offer new insight into the hepatotoxicity mechanism associated with the metabolic activation of CAR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CarvedilolChemical and Drug Induced Liver InjuryAntihypertensive AgentsCytochrome P-450 Enzyme SystemAnimalsMaleMicrosomes, LiverRats, Sprague-DawleyActivation, MetabolicRatsGlutathioneHumansCytochrome P-450 CYP3AHepatocytesCell SurvivalAcetylcysteineLiver

Stichwörter der Autor:innen

CYP3A4CarvedilolHepatotoxicityMetabolic activation

Substanzen

CarvedilolGlutathioneCytochrome P-450 CYP3AAcetylcysteineAntihypertensive AgentsCytochrome P-450 Enzyme System

Autor:innen und Institutionen

  • Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, PO Box 21, Shenyang, 110016, Liaoning, People's Republic of China.
  • School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, People's Republic of China.
  • State Key Laboratory of Discovery and Utilization of Functional Components in Traditional Chinese Medicine, Engineering Research Center for the Development and Application of Ethnic Medicine and TCM (Ministry of Educati…
  • College of Traditional Chinese Materia Medica, Shenyang Pharmaceutical University, 103 Wenhua Road, PO Box 21, Shenyang, 110016, Liaoning, People's Republic of China. 2353539001@qq.com.
  • Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, PO Box 21, Shenyang, 110016, Liaoning, People's Republic of China. yingpeng1999@163.com.
  • Wuya College of Innovation, Shenyang Pharmaceutical University, 103 Wenhua Road, PO Box 21, Shenyang, 110016, Liaoning, People's Republic of China. zhengjiang@syphu.edu.cn.

ORCID-Profile: Jiang Zheng

Zitieren

APA

Sun, S., Wang, Y., Shen, Y., Li, W., Hu, Z., Peng, Y., & Zheng, J. (2025). Metabolic activation and cytotoxicity of carvedilol mediated by cytochrome P450s in vitro and in vivo. Archives of Toxicology. https://doi.org/10.1007/s00204-025-04054-8

Vancouver

Sun S, Wang Y, Shen Y, Li W, Hu Z, Peng Y, et al. Metabolic activation and cytotoxicity of carvedilol mediated by cytochrome P450s in vitro and in vivo. Archives of Toxicology. 2025. doi:10.1007/s00204-025-04054-8

BibTeX
@article{Sun2025,
  author = {Sun, Shibo and Wang, Yang and Shen, Yan and Li, Weiwei and Hu, Zixia and Peng, Ying and Zheng, Jiang},
  title = {Metabolic activation and cytotoxicity of carvedilol mediated by cytochrome P450s in vitro and in vivo},
  journal = {Archives of Toxicology},
  year = {2025},
  doi = {10.1007/s00204-025-04054-8}
}
Kostenlos starten →